Mutational profile analysis indicated that patients with biallelic TP53 inactivation had specific genetic alterations, with different co-occurring patterns from those observed in patients with MDS-IB or MDS-f (Supplementary Fig. 3, and Supplementary Table 4b). The gene discussed is TP53; the disease is myelodysplastic syndrome.